Princeton
-
FDA approves Taiho drug for rare bile duct cancer with certain genetic signature
Taiho Oncology’s cancer drug Lytgobi is the third FDA-approved therapy for bile duct cancer driven by FGFR2 genetic alterations. The accelerated approval for Taiho’s drug follows regulatory nods for products from Incyte and QED Therapeutics that address the same genetic signature.
-
Pharma, BioPharma, Artificial Intelligence
Princeton spinout ArrePath gets $20M to combine AI, imaging in antibiotics R&D
Anti-infective drug discovery startup ArrePath has launched with $20 million in seed funding to advance the development of molecules that use a dual mechanism to kill bacteria. The Princeton University spinout says its approach could overcome the drug resistance bacteria are developing to currently available products.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
Oyster Point dry eye drug is approved, but omission in label crimps financing plan
An Oyster Point Pharma drug for dry eye disease has won FDA approval, the first treatment for the condition that comes as a nasal spray. In addition to that drug approval, the FDA on Monday rejected two drugs, one from Omeros and the other from United Therapeutics.
-
ThirdEye Gen partners with Dolphin Medical Imaging to bring mixed reality tech to healthcare
Initially the idea being the collaboration with Dolphin Medical is to use the device to make it easier for clinicians to find blood vessels for the placement of catheters.
-
Princeton University and ODH ally for machine learning research project
Princeton University’s Department of Operations Research and Financial Engineering and ODH will research and develop machine learning techniques focused on the mental and social factors impacting patients.
-
Merck CEO takes a stand and resigns from Trump’s Manufacturing Council (Updated)
Frazier’s departure was later followed by a string of executive resignations from the manufacturing council this week before Trump announced Wednesday he would disband it.
-
J&J’s global public health crowdfunding website strikes a balance between tech and social good
In addition to supporting programs in disease prevention and improving access to care in developing countries, CaringCrowd has also hosted projects raising funds for underserved populations in the U.S.
-
Health IT, Devices & Diagnostics
Hill-Rom sells WatchChild fetal monitor to AI company PeriGen
The sale, announced Tuesday, will allow PeriGen to apply its clinical decision support and artificial intelligence to the WatchChild obstetrics device and offer an integrated product. It also allows Hill-Rom to shed a product that doesn’t quite fit its core mission.
-
Would body cameras on physicians aid patient safety?
Steven Strauss, a visiting professor at Princeton University’s Woodrow Wilson School of Public and International Affairs, raised the issue in a Monday op-ed in the Los Angeles Times.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Ranbaxy spinout gets $6.5M for N.J.-based generics biz
Bionpharma just raised $6.5 million, according to a regulatory filing – on top of about $31 million raised last year.
-
Health IT, Hospitals, Startups
VOX Telehealth rolls out program to cut hip replacement surgery costs
VOX Telehealth, a health IT company that uses alerts and notifications as part of a […]
-
Health IT, Hospitals, Startups
Vitals adds price transparency to doctor reviews with acquisition
Vitals’ acquisition of Compass Healthcare Advisers brings together two criteria that consumers can use to […]